Well right now he's a needle in haystack with his opinion. I think majority of analysts and opinions are predicting a revised bid so we shall see who gets it right.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025